TO ALL KNOWLEDGE BASE VISITORS: BE WARY OF...CHAT BOARD MANIPULATORS. THESE PAGES AND LINKS ARE ONLY INFORMATIONAL, NOT PROMOTIONAL. QUESTION ANYONE WHO HYPES OR BASHES ANY STOCK. SEE MAIN PAGE FOR MORE CHAT BOARD HAZARDS INFO. PLEASE USE CAUTION IN ALL INVESTMENT MATTERS.

Overview: CEL-SCI Corp. Projects
                  Current status, recent updates

Please note: By 1996, CEL-SCI Corp. (CELI, HIV, CVM) had commenced work with proprietary products Multikine, HGP-30W, and L.E.A.P.S. During this period several U.S., Canada, and overseas Phase 1 and Phase 2 clinical trials were initiated. A new compound, CEL-1000, was recently integrated into company's development programs.

CEL-SCI Corp. Product Chart
Multikine    HGP-30W    L.E.A.P.S.    CEL-1000
  • 2003 NE Ohio Universities/Viral Encephalitis/CEL-1000, Recent Announcement

    Funding Source: Grant
    Current Status: New collaboration
  • 2002 University of Arkansas/Genital Chlamydia/CEL-1000, Recent Announcement

    Funding Source: UARK staff and facilities utilized
    Current Status: New collaboration
  • 2002 Proxima Concepts, Ltd./Oral Formulation/CEL-1000, Recent Announcement

    Funding Source: Proxima Concepts, Ltd. of London, UK
    Current Status:     New collaboration

  • 1996 - 2002 Various studies/H & N Cancer/Multikine results, more recent results

    Funding Source:     company financed, utilizing facilities and labor of several overseas labs
    Current Status     of H & N Cancer study: continuing, latest update.

  • 2001 BioMedex, Inc./Anthrax Test/Development agreement announced

    Funding Source: Biomedex responsible for project funding
    Current Status of Anthrax Test: as yet uninitiated, seeking funding.

  • 2001 NCI/Breast and Prostate Cancer/L.E.A.P.S. 

    Funding Source:     CRADA re-funded
    Current Status     of Breast, Prostate studies: continuing, no recent updates.

  • 2000 NCI/HIV Peptide Epitopes/L.E.A.P.S. alliance announced

    Funding Source:     CRADA Grant/NCI alliance
    Current Status     of Peptide project: continuing, no recent updates.

  • 2000 Johns-Hopkins/Myocarditis/L.E.A.P.S./AdapT alliance announced, results.

    Funding Source:     MIPS Award
    Current Status     of Myocarditis project: continuing.
  • 1999 Thomas Jefferson Univ./Prostate Cancer/Multikine alliance announced, 

    Funding Source:     Thomas Jefferson Univ. alliance
    Current Status     of 2nd Prostate Cancer study: continuing, no recent updates.
  • 1998 HGP-30W Company in most of '98 focused on HIV vaccine research. P2 Trial, results, more recent results

         Funding Source: Institute for Clinical Pharmacology, Pharma BioResearch, Netherlands
    Current Status of HGP-30W Vaccine: inactive, lacks funding.     Project eventually shelved in '99 - '00. No collaborative alliances obtained. South Africa free license offer

  • 1997 University of Maryland/TB Diagnostic Test alliance announced, re-funded.

    Funding Source:     MIPS Award
    Current Status     of TB Diagnostic Test: Status unknown, no recent updates.

  • 1996 University of Maryland/AIDS Diagnostic Kit patent update

    Funding Source:     Grant
    Current Status     of AIDS Diagnostic Kit: inactive or status unknown. No recent updates.

  • 1996 AIDS Alliance/HIV Vaccine/HGP-30W study results1, 

         Funding Source: AIDS Research Alliance
    Current Status     of HGP-30W vaccine: inactive, project 'shelved' for lack of funding.